Resultados da pesquisa - (( j nasr como can netw ) OR ((( 5 nail company can new ) OR ( a small companies _ non ))))

Pesquisas alternativas:
nasr » nas (Expandir a Pesquisa), nar (Expandir a Pesquisa), nair (Expandir a Pesquisa)
como » com (Expandir a Pesquisa)
netw » net (Expandir a Pesquisa), neto (Expandir a Pesquisa), nets (Expandir a Pesquisa)
nail » natl (Expandir a Pesquisa), neil (Expandir a Pesquisa), nair (Expandir a Pesquisa)

1

Impact of Increased Gastric pH on the Pharmacokinetics of Evacetrapib in Healthy Subjects

Impact of Increased Gastric pH on the Pharmacokinetics of Evacetrapib in Healthy Subjects

Por Small, David S., Royalty, Jane, Cannady, Ellen A., Hale, Christine, Wang, Ming‐Dauh, Downs, Delyn, Suico, Jeffrey G.
Publicado no Pharmacotherapy (2016)

“...STUDY OBJECTIVE: To examine the effect of increased gastric pH on exposure to evacetrapib, a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

External beam techniques to boost cervical cancer when brachytherapy is not an option—theories and applications

External beam techniques to boost cervical cancer when brachytherapy is not an option—theories and applications

Por Mahmoud, Omar, Kilic, Sarah, Khan, Atif J., Beriwal, Sushil, Small, William
Publicado no Ann Transl Med (2017)

“... represent viable options that must be adequately executed in a timely manner. However, if these options...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

3

Innate immune responses to gut microbiota differ between oceanic and freshwater threespine stickleback populations

Innate immune responses to gut microbiota differ between oceanic and freshwater threespine stickleback populations

Por Milligan-Myhre, Kathryn, Small, Clayton M., Mittge, Erika K., Agarwal, Meghna, Currey, Mark, Cresko, William A., Guillemin, Karen
Publicado no Dis Model Mech (2016)

“... describe a new gnotobiotic vertebrate model to explore the natural genetic variation that contributes...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

4

Combinatorial activation and concentration-dependent repression of the Drosophila even skipped stripe 3+7 enhancer

Combinatorial activation and concentration-dependent repression of the Drosophila even skipped stripe 3+7 enhancer

Por Struffi, Paolo, Corado, Maria, Kaplan, Leah, Yu, Danyang, Rushlow, Christine, Small, Stephen
Publicado em 2011

“... for activation, and present evidence that Zld binds to multiple non-canonical sites. We also use a combination...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

5

Integrating gender and sex to unpack trends in sexually transmitted infection surveillance data in British Columbia, Canada: an ethno-epidemiological study

Integrating gender and sex to unpack trends in sexually transmitted infection surveillance data in British Columbia, Canada: an ethno-epidemiological study

Por Knight, Rod, Falasinnu, Titilola, Oliffe, John L, Gilbert, Mark, Small, Will, Goldenberg, Shira, Shoveller, Jean
Publicado no BMJ Open (2016)

“...'s experiences accessing STI testing services in five communities in British Columbia, Canada. These data...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

6

Evacetrapib: in vitro and clinical disposition, metabolism, excretion, and assessment of drug interaction potential with strong CYP3A and CYP2C8 inhibitors

Evacetrapib: in vitro and clinical disposition, metabolism, excretion, and assessment of drug interaction potential with strong CYP3A and CYP2C8 inhibitors

Por Cannady, Ellen A, Wang, Ming-Dauh, Friedrich, Stuart, Rehmel, Jessica L F, Yi, Ping, Small, David S, Zhang, Wei, Suico, Jeffrey G
Publicado no Pharmacol Res Perspect (2015)

“... guide prescribing recommendations. In vitro, evacetrapib metabolism was investigated with a panel...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

7

Supporting breastfeeding In Local Communities (SILC) in Victoria, Australia: a cluster randomised controlled trial

Supporting breastfeeding In Local Communities (SILC) in Victoria, Australia: a cluster randomised controlled trial

Por McLachlan, Helen L, Forster, Della A, Amir, Lisa H, Cullinane, Meabh, Shafiei, Touran, Watson, Lyndsey F, Ridgway, Lael, Cramer, Rhian L, Small, Rhonda
Publicado no BMJ Open (2016)

“... centres in the LGAs comprised the clusters. INTERVENTIONS: Early home-based breastfeeding support by a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

8

STRATEGIES FOR RETENTION GLOBAL LEADERSHIP OF SMALL HIGH-TECH COMPANIES IN NARROWLY FOCUSED MARKETS

STRATEGIES FOR RETENTION GLOBAL LEADERSHIP OF SMALL HIGH-TECH COMPANIES IN NARROWLY FOCUSED MARKETS

Por F. A. Kurakov
Publicado em 2018-09-01

Assuntos: “...small- and medium-sized high-tech companies...”
Obter o texto integral

Artigo

9

AB041. Effectiveness and cost impact evaluation of fluticasone propionate/formoterol compared to fluticasone propionate/salmeterol

AB041. Effectiveness and cost impact evaluation of fluticasone propionate/formoterol compared to fluticasone propionate/salmeterol

Por Ming, Simon Wan Yau, Small, Iain, Wolfe, Stephanie, Hamil, John, Gruffydd-Jones, Kevin, Daly, Cathal, Soriano, Joan B., Gardner, Liz, Skinner, Derek, Price, David
Publicado no J Thorac Dis (2016)

“.... To determine whether FP/FOR is non-inferior to FP/SAL in patients who initiate or switch to a FDC ICS/LABA...”
Obter o texto integral
Obter o texto integral

Artigo

10

The Concession Agreement as a Form of Involving Small Private Companies into the Effective Management of State Property

The Concession Agreement as a Form of Involving Small Private Companies into the Effective Management of State Property

Por O. Malikova, A. M. Maksimova
Publicado em 2017-12-01

Assuntos: “...private company...”
Obter o texto integral

Artigo

11

Biomarkers in the selection of maintenance therapy in non-small cell lung cancer

Biomarkers in the selection of maintenance therapy in non-small cell lung cancer

Por Tanner, Nichole T., Sherman, Carol A., Silvestri, Gerard A.
Publicado no Transl Lung Cancer Res (2012)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

12

Hypersensitivity reactions to carboplatin and cisplatin in non-small cell lung cancer

Hypersensitivity reactions to carboplatin and cisplatin in non-small cell lung cancer

Por Randall, J. Michael, Bharne, Anjali A., Bazhenova, Lyudmila A.
Publicado em 2013

“...Non-small cell lung cancer (NSCLC) treatment has changed in the past ten years due...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

13

Financial planning and access to financing in small and mediumsized companies in the Venezuelan manufacturing sector

Financial planning and access to financing in small and mediumsized companies in the Venezuelan manufacturing sector

Por Mary A. Vera-Colina, Guillermo Rodríguez-Medina, Zuray Melgarejo-Molina
Publicado no INNOVAR. Revista de Ciencias Administrativas y Sociales (2011)

Assuntos: “...Small and medium...”
Obter o texto integral

Artigo

14

Default options in advance directives: study protocol for a randomised clinical trial

Default options in advance directives: study protocol for a randomised clinical trial

Por Gabler, Nicole B, Cooney, Elizabeth, Small, Dylan S, Troxel, Andrea B, Arnold, Robert M, White, Douglas B, Angus, Derek C, Loewenstein, George, Volpp, Kevin G, Bryce, Cindy L, Halpern, Scott D
Publicado no BMJ Open (2016)

“... 1 of 3 different ADs: (1) a traditional AD that requires patients to actively choose their goals...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

15

Non-invasive diagnostic platforms in management of non-small cell lung cancer: opportunities and challenges

Non-invasive diagnostic platforms in management of non-small cell lung cancer: opportunities and challenges

Por Velcheti, Vamsidhar, Pennell, Nathan A.
Publicado no Ann Transl Med (2017)

“... technologies available for non-invasive diagnostic evaluation from the blood of patients with non-small cell...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

16

The KEY to the end of chemotherapy in non-small cell lung cancer?

The KEY to the end of chemotherapy in non-small cell lung cancer?

Por Huang, Yiqing, Soo, Ross A.
Publicado no Ann Transl Med (2017)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

17

New strategies in immunotherapy for non-small cell lung cancer

New strategies in immunotherapy for non-small cell lung cancer

Por Carrizosa, Daniel R., Gold, Kathryn A.
Publicado no Transl Lung Cancer Res (2015)

Assuntos: “...Review Article on Lung Cancer Diagnostics and Treatments 2015: A Renaissance of Patient Care...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

18

Immunotherapy in previously treated non-small cell lung cancer (NSCLC)

Immunotherapy in previously treated non-small cell lung cancer (NSCLC)

Por Leal, Ticiana A., Ramalingam, Suresh S.
Publicado no J Thorac Dis (2018)

“... diagnosed with metastatic non-small cell lung cancer (NSCLC) and its use is currently an established...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

19

Non-small cell lung cancer: current treatment and future advances

Non-small cell lung cancer: current treatment and future advances

Por Zappa, Cecilia, Mousa, Shaker A.
Publicado no Transl Lung Cancer Res (2016)

“... year of diagnosis and the 5-year survival is less than 18%. Non-small cell lung cancer (NSCLC) accounts...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

20

License Compliance Issues For Biopharmaceuticals: Special Challenges For Negotiations Between Companies And Non-Profit Research Institutions

License Compliance Issues For Biopharmaceuticals: Special Challenges For Negotiations Between Companies And Non-Profit Research Institutions

Por Ponzio, Todd A., Feindt, Hans, Ferguson, Steven
Publicado em 2011

“... by regulatory requirements, that must be met to bring a new drug to market, such as completion of preclinical...”
Obter o texto integral
Obter o texto integral

Artigo

1
2
3
4
5
6
7
8
9
10
11
Seguinte
[88]